📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ViaCyte

1.1 - Company Overview

ViaCyte Logo

ViaCyte

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of preclinical regenerative medicine therapies for diabetes, based on differentiation of stem cells into pancreatic beta-cell precursors implanted subcutaneously in an encapsulation device.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ViaCyte

BioRestorative Therapies Logo

BioRestorative Therapies

HQ: United States Website
  • Description: Provider of cellular-based therapies using cell and tissue protocols, including BRTX-100, an autologous stem cell product for chronic lower back pain due to degenerative disc disease, and ThermoStem, a brown adipose-derived stem cell program to generate new brown fat targeting obesity and metabolic disorders; also conducts clinical trials, including a Phase 2 trial for BRTX-100.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioRestorative Therapies company profile →
Sigilon Therapeutics Logo

Sigilon Therapeutics

HQ: United States Website
  • Description: Provider of immune-privileged, immune-protected engineered human cell products to treat acute and chronic diseases by restoring normal physiology while aiming to avoid fibrosis and immune rejection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sigilon Therapeutics company profile →
OxThera Logo

OxThera

HQ: Sweden Website
  • Description: Provider of biopharmaceutical treatments for primary and secondary hyperoxaluria, developing late-stage oral therapies: Oxabact, which promotes secretion of oxalate from plasma into the gut for degradation in patients with Primary Hyperoxaluria; and Oxazyme, a recombinant oxalate decarboxylase that degrades dietary oxalate in the gut for Secondary Hyperoxaluria.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OxThera company profile →
Betagenon Logo

Betagenon

HQ: Sweden Website
  • Description: Provider of AMPK activator compound development to treat chronic energy balance disorders in metabolically challenged elderly and/or obese individuals, with expected beneficial effects on metabolic and cardiovascular diseases; a Sweden-based biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Betagenon company profile →
Nexus BioPharma Logo

Nexus BioPharma

HQ: United States Website
  • Description: Provider of preclinical-stage biotechnology research and development focused on developing new therapies and intellectual property.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nexus BioPharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ViaCyte

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ViaCyte

2.2 - Growth funds investing in similar companies to ViaCyte

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ViaCyte

4.2 - Public trading comparable groups for ViaCyte

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ViaCyte

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ViaCyte

What does ViaCyte do?

ViaCyte is a provider of preclinical regenerative medicine therapies for diabetes, based on differentiation of stem cells into pancreatic beta-cell precursors implanted subcutaneously in an encapsulation device.

Who are ViaCyte's competitors?

ViaCyte's competitors and similar companies include BioRestorative Therapies, Sigilon Therapeutics, OxThera, Betagenon, and Nexus BioPharma.

Where is ViaCyte headquartered?

ViaCyte is headquartered in United States.

How many employees does ViaCyte have?

ViaCyte has 1,000 employees 🔒.

When was ViaCyte founded?

ViaCyte was founded in 2010 🔒.

What sector and industry vertical is ViaCyte in?

ViaCyte is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ViaCyte

Who are the top strategic acquirers in ViaCyte's sector and industry

Top strategic M&A buyers and acquirers in ViaCyte's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ViaCyte?

Top strategic M&A buyers groups and sectors for ViaCyte include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ViaCyte's sector and industry vertical

Which are the top PE firms investing in ViaCyte's sector and industry vertical?

Top PE firms investing in ViaCyte's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ViaCyte's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ViaCyte's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ViaCyte's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ViaCyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ViaCyte's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ViaCyte?

The key public trading comparables and valuation benchmarks for ViaCyte include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ViaCyte for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ViaCyte with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ViaCyte's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ViaCyte with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ViaCyte's' sector and industry vertical?

Access recent funding rounds and capital raises in ViaCyte's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ViaCyte